
News|Articles|August 16, 2024
Crystallization process development
Author(s)Veranova
Trending on Pharmaceutical Technology
1
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
2
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
3
The FDA Moves to Modernize Drug Manufacturing Registration
4
PharmTech Weekly Roundup–July 10, 2026
5